• Increase
  • Decrease
  • Normal

Current Size: 100%

Ed Forum 2018

Presentations for Where Do We Go From Here?

Making Choices About Your Health with Your Team

Danny van Leeuwen, RN, MPH, 2018 Ed Forum
Presents advice regarding how to approach living with a serious illness and how to enhance the patient experience through quality improvement.

Link to vanLeeuwen slides

Translating Genomic Findings into New Treatment Opportunities for WM

Steven Treon, MD, PhD – Dana-Farber Cancer Institute, 2016 Ed Forum
Reviews WM-centric toxicities with commonly used therapies and discusses new directions in WM based on the MYD88 L265P somatic mutation in WM

Link to Treon slides

MYD88, CXCR4, & the Molecular Basis of WM

Zachary Hunter, PhD – Dana Farber Cancer Institute, 2016 Ed Forum
Reviews genetics, epigenetics and the epigenome, including the genomics of WM

No video available

Link to Hunter slides

Cellular Immunotherapy for Lymphoid Cancers

Edward Stadtmauer, MD, University of Pennsylvania, 2016 Ed Forum
Covers the manifestations of WM, immunologic approaches to overcome self-tolerance in lymphoma, rationale for cellular immunotherapy in lymphoma, adoptive T-cell therapy, second generation of CAR for B-cell malignancies, overview of activated/engineered T-cell therapy, CD19-targeted CAR T-cells for B-cell malignancies, phase I trial for CLL, results with diffuse large B-cell lymphoma, follicular lymphoma and adverse events, pilot study of CART19 in multiple myeloma, CART-BCMA cells for multiple myeloma, and potential strategies to improve CART therapy in lymphoma

Link to Stadtmauer slides

Frontline Treatment Options for WM

Jorge Castillo, MD - Dana-Farber Cancer Institute, 2016 Ed Forum
Reviews the manifestations of WM disease, NCCN guidelines for initiation of treatment for WM, single agent treatments, combination therapies, maintenance, and new directions, including frontier clinical trials at Dana Farber Cancer Institute

Link to Castillo slides

The Strategic Research Roadmap for WM

Lee Greenberger, PhD - The Leukemia and Lymphoma Society, 2015 Ed Forum
Covers who is LLS, what are their interests in WM, what have they funded, what is the road ahead, and how will we fund the future

No video available

Link to Greenberger slides

My WM is Back–Relapsed/Refractory Treatments

Sheeba Thomas, MD - MD Anderson Cancer Center, 2015 Ed Forum
Explores diagnosis, recommendations for treating relapsed WM, clinical trials, and future therapies

Link to Thomas slides

I’ve Been Diagnosed with WM – What Happens Now?

Joseph Mikhael, MD, MEd - Mayo Clinic, Arizona, 2015 Ed Forum
Reviews the basics of Waldenstrom’s Macroglobulinemia and how it is distinguished from myeloma and lymphoma.
Discusses the importance of an accurate diagnosis in WM.
Highlights the critical features to establish the need to treat WM.
Outlines the overall approach to therapy of WM.
Empowers you for the rest of this conference and your disease “career.”

Link to Mikhael slides

Progress in Indolent Lymphoma: Is Chemotherapy Dead?

Bruce Cheson, MD - Georgetown University, 2014 Ed Forum
Reviews chemotherapy and where are we going in treatment strategies and clinical trials, problems in new drug development, and issues for the future

Link to Cheson slides

Novel Treatments for WM

Peter Martin, MD - Weill Cornell Medical College, 2014 Ed Forum
Discusses the consensus recommendations of the 4th International WM meeting and then presents how drug development proceeds in WM with a discussion of new therapies and clinical trials

No video available

Link to Martin slides

Google Adwords: